COVID-19

Modulation of pentose phosphate pathway augments the efficacy of 2-deoxy-D-glucose in COVID-19 management

Scientists and clinicians around the world have been investigating various drug targets and potential therapeutics for COVID-19, the disease caused by SARS-CoV-2. On May 8, 2021, the Defence Research and Development Organisation (DRDO) announced that its anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) had been approved by the Drug Controller General of India (DCGI). […]

Modulation of pentose phosphate pathway augments the efficacy of 2-deoxy-D-glucose in COVID-19 management Read More »

Spatio‑temporal epidemiology and associated indicators of COVID‑19 (wave‑I and II) in India

The COVID-19 pandemic, which began in December 2019, has profoundly impacted millions of families in India, affecting their physical, mental, and economic well-being. The first wave peaked in September 2020, with a gradual decline until February 2021, largely due to a nationwide lockdown, resulting in relatively mild outcomes. However, the second wave, from February to

Spatio‑temporal epidemiology and associated indicators of COVID‑19 (wave‑I and II) in India Read More »

Scroll to Top